|
 |
Articles
New Products
October 10, 2009 - The FDA has approved a new drug that combines 85 mg of sumatriptan and 500 mg of Naproxen. Sumatriptan (Imitrex) targets the nerves and blood vessels and while very effective for most migraineurs works in ways scientists no not yet understand. Naproxen relieves inflammation.
The brand name is Treximet. It is made by GlaxoSmithKIline.
|
 |
 |
Links
Home
News From Migraine Research
Research Reports
Professional Abstracts
Migraine Overview
Other Sources
Terms of Use
Privacy Policy
|
 |
